GLF
ADPT icon

Groupe la Francaise’s Adaptive Biotechnologies ADPT Stock Holding History

Groupe la Francaise’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$1.15K – 467
2025
Q3 		$1.15K Buy
+100
New +$1.22K ﹤0.01% 735

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Groupe la Francaise's ADPT Position: Q4 2025 in Review

Groupe la Francaise sold out of Adaptive Biotechnologies (ADPT) in Q4 2025, closing a stake of 100 shares — an estimated $1.15K sold.

Groupe la Francaise first reported a position in ADPT in Q3 2025 and held it in 1 quarter. The position peaked at $1.15K in Q3 2025. 283 funds tracked by Wall St. Rank hold ADPT as of Q4 2025.

  • Groupe la Francaise reported no remaining Adaptive Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 100 Adaptive Biotechnologies shares in Q4 2025, an estimated $1.15K.
  • Groupe la Francaise first reported a position in Adaptive Biotechnologies in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's Adaptive Biotechnologies position peaked at $1.15K in Q3 2025.
  • 283 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.